Glamorous AI

Drug discovery

GlamorousAI is an AI-first preclinical biotech focusing on the discovery of novel chemistry for challenging targets, where no or only a few binders are known, enabling first-in-class therapeutics on stalled or novel targets.

Focus: Drug discovery platform / SAAS 

Team: Noor Shaker


Be part of SBC Catalyser Programme!

Spaces are limited to a maximum of 10 companies per cohort. Contact Marco to know more or to apply.

Contact Marco

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.